Porokeratosis, Linear
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
3
|
|
0.320 |
moderate |
1.000 |
2 |
|
2019 |
2019 |
Porokeratosis, Disseminated Superficial Actinic
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
12
|
1
|
0.310 |
None |
1.000 |
1 |
|
2015 |
2019 |
Porokeratosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases
|
Congenital Abnormality
|
8
|
|
0.120 |
None |
1.000 |
2 |
|
2017 |
2019 |
Squamous cell carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2325
|
197
|
0.110 |
None |
1.000 |
1 |
|
2004 |
2004 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10153
|
1571
|
0.100 |
None |
0.947 |
19 |
|
2004 |
2020 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6345
|
327
|
0.060 |
None |
1.000 |
6 |
|
2004 |
2019 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.050 |
None |
1.000 |
5 |
|
2008 |
2018 |
MYELODYSPLASTIC SYNDROME
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
975
|
79
|
0.050 |
None |
1.000 |
5 |
|
1994 |
2011 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8577
|
1441
|
0.050 |
None |
1.000 |
5 |
|
2003 |
2019 |
Juvenile Myelomonocytic Leukemia
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
174
|
26
|
0.040 |
None |
0.750 |
4 |
|
1996 |
2013 |
Chronic myeloproliferative disorder
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
351
|
44
|
0.040 |
None |
1.000 |
4 |
|
2006 |
2013 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.040 |
None |
1.000 |
4 |
|
2015 |
2019 |
Primary Myelofibrosis
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
263
|
25
|
0.040 |
None |
1.000 |
4 |
|
2006 |
2014 |
Myelofibrosis
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
161
|
7
|
0.040 |
None |
1.000 |
4 |
|
2006 |
2014 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6481
|
2154
|
0.030 |
None |
1.000 |
3 |
|
2014 |
2015 |
Hyalinosis, Systemic
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
20
|
17
|
0.030 |
None |
1.000 |
3 |
|
2018 |
2019 |
Myeloproliferative disease
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
355
|
35
|
0.030 |
None |
1.000 |
3 |
|
2006 |
2013 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6500
|
2145
|
0.030 |
None |
1.000 |
3 |
|
2014 |
2015 |
Polycythemia Vera
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
283
|
37
|
0.020 |
None |
0.500 |
2 |
|
2006 |
2008 |
Noonan Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
77
|
65
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2013 |
Malignant neoplasm of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2520
|
246
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2020 |
Thrombocythemia, Essential
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
212
|
32
|
0.020 |
None |
1.000 |
2 |
|
2006 |
2006 |
Porokeratosis of Mibelli
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
9
|
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
Trigeminal Neuralgia
|
disease |
Nervous System Diseases; Stomatognathic Diseases
|
Disease or Syndrome
|
91
|
1
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2018 |
Leukemogenesis
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
996
|
25
|
0.020 |
None |
1.000 |
2 |
|
1990 |
1996 |